Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Safe, broad-spectrum quinolones from Wakunaga

Sep. 20, 1996

New quinolone from Bayer undergoing extensive evaluation

Sep. 20, 1996

Potential new analgesic agent from SmithKline Beecham

Sep. 20, 1996

Stroke Update

Sep. 13, 1996

Orally active GH secretagogues with a short duration of action

Sep. 13, 1996

Achiral inhibitors of carnitine palmitoyltransferase I

Sep. 13, 1996

Warner-Lambert focuses on endothelin antagonists

Sep. 13, 1996

Merck & Co. describes endothelin antagonists

Sep. 13, 1996

Selective dual inhibitor of PDE I and PDE V from Schering-Plough

Sep. 13, 1996

Potential antiasthmatic agent from Lipha

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...